Significant Ownership of Bain Capital Life Sciences Fund, L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Bain Capital Life Sciences Fund, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Andrew Hack - Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC
- Manager location
- Boston, MA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Bain Capital Life Sciences Fund, L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Bain Capital Life Sciences Fund, L.P.
Significant Ownership of Bain Capital Life Sciences Fund, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RPID | Rapid Micro Biosystems, Inc. | Class A Common Stock, par value $0.01 per share | 17% | $13,160,355 | 7,651,369 | Bain Capital Life Sciences Fund, L.P. | 30 Jun 2026 | ||
| ANNX | Annexon, Inc. | Common Stock, par value $0.001 per share | 4.9% | $9,973,231 | 5,249,069 | BCLS I Investco, LP | 31 Dec 2024 | ||
| PHVS | Pharvaris N.V. | Ordinary Shares, Euro 0.12 par value per share | 2.5% | $41,020,425 | -$5,670,300 | 1,640,817 | -12% | Bain Capital Life Sciences Fund, L.P. | 31 Dec 2025 |
| XFOR | X4 PHARMACEUTICALS, INC. | Common Stock, par value $0.001 per share | 0% | $0 | -$9,478,327 | 0 | -100% | Bain Capital Life Sciences Fund, L.P. | 31 Dec 2025 |
Schedules 13D/G Reported by Bain Capital Life Sciences Fund, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.